|
In December 2021, the U.S. Food and Drug Administration (FDA) authorized Paxlovid for emergency use for the treatment of adults and pediatric patients (12 years of age and older weighing at least 40 kg) who are at high risk for progression to severe COVID-19, including hospitalization or death. In May 2023, FDA approved Pfizer’s new drug application (NDA) for Paxlovid for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.
On January 29, 2024, the FDA announced a revision to the Paxlovid emergency use authorization (EUA), stating that Paxlovid manufactured and labeled in accordance with the EUA (EUA-labeled Paxlovid) currently in U.S. distribution will remain authorized for use through the labeled or extended expiration date, as applicable, or through March 8, 2024, whichever is earlier.
EUA-labeled Paxlovid will no longer be authorized for emergency use after March 8, 2024, regardless of the labeled or extended expiration date. However, the Paxlovid EUA will continue to authorize emergency use of Paxlovid manufactured and labeled in accordance with the NDA (NDA-labeled Paxlovid) for the treatment of mild-to-moderate COVID-19 in pediatric patients (12 years of age and older weighing at least 40 kg) who are at high risk for progression to severe COVID-19, including hospitalization or death. L
The federal government’s free at-home COVID-19 test program will be suspended beginning Friday, March 8 in response to a drop in respiratory diseases. The Biden administration brought back the free test program last year ahead of the respiratory viral season. By going to https://COVIDtests.gov, households could order a free pack of four at-home COVID-19 tests. This most recent batch of free tests was the sixth round made available. All orders placed on or before March 8 will be delivered. “The program may be brought back again in the future as needed.
Join NACCHO for our March Infection Prevention and Control Living Learning Network call on Wednesday, March 13, 12pm-1pm ET. We will be joined by Cardea Services and local health department representatives from Florida Department of Health in Polk County and Prince George's County, Maryland, to reflect on how NACCHO's Essential Skills trainings have impacted IPC work on the local level, what barriers still exist in applying lessons learned, and what improvements could be made to the trainings. This call will be interactive and is designed for feedback and reflection.
|
